Biopure Auctions Assets to OPK

Xconomy Boston — 

Biopure, the financially distressed Cambridge, MA, developer of blood substitutes, said in an SEC filing yesterday that its assets were sold in a bankruptcy court auction as planned to OPK Biotech, a Delaware corporation, for $4 million. OPK also plans to buy Biopure’s real estate assets for $850,000. Biopure planned to work with OPK to close the sale of its assets within 30 days. Mass Device blog reports that Biopure’s new owner OPK is controlled by a Russian entrepreneur, Sergei Pugachev, whose personal fortune in mining, retail, and other industries has been estimated to be worth billions of dollars.